Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066371
Filing Date
2025-05-08
Accepted
2025-05-08 07:11:49
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qttb-20250331.htm   iXBRL 10-Q 2517577
2 EX-31.1 qttb-ex31_1.htm EX-31.1 15458
3 EX-31.2 qttb-ex31_2.htm EX-31.2 15453
4 EX-32.1 qttb-ex32_1.htm EX-32.1 9503
5 EX-32.2 qttb-ex32_2.htm EX-32.2 9498
  Complete submission text file 0000950170-25-066371.txt   10617799

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT qttb-20250331.xsd EX-101.SCH 1729257
95 EXTRACTED XBRL INSTANCE DOCUMENT qttb-20250331_htm.xml XML 1678848
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38433 | Film No.: 25923833
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)